Orbimed Advisors LLC Milestone Pharmaceuticals Inc. Transaction History
Orbimed Advisors LLC
- $3.69 Billion
- Q4 2024
A detailed history of Orbimed Advisors LLC transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 2,000,000 shares of MIST stock, worth $4.08 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
2,000,000
Previous 2,000,000
-0.0%
Holding current value
$4.08 Million
Previous $3.04 Million
55.26%
% of portfolio
0.13%
Previous 0.07%
Shares
7 transactions
Others Institutions Holding MIST
# of Institutions
51Shares Held
25.1MCall Options Held
61.2KPut Options Held
38.8K-
Black Rock Inc. New York, NY4.97MShares$10.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.7MShares$5.51 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY2.66MShares$5.42 Million2.16% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$5.11 Million0.1% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.45MShares$2.95 Million0.17% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $61.2M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...